Bristol-Myers Squibb Company Ce

CELG-RINYSEHealthcare● Active

$0.11

+$0.01(+10.33%)

Market Cap$224627700

P/E Ratio—

52W High$0.123

52W Low$0.0998

Avg Volume38K

Open$0.12

Beta-0.54

Net Income Financials Revenue

Bristol-Myers Squibb Company Ce (CELG-RI) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

CELG-RI · net income · updated Jun 8, 2026

Core profitability metrics

CELG-RI · net income · margin · TTM · CAGR

Net income was $4.05B for FY2018 (fiscal year ending 2018-12-31), up 37.6% year-over-year. Net profit margin was 26.5%. Based on available data, Bristol-Myers Squibb Company Ce has been profitable since at least 2007.

FY2018 Net Income$4.05B▲ +37.6% YoY

Trailing 12M (TTM)$5.88Btrailing 4 quarters sum

Net Profit Margin26.5%$4.05B ÷ $15.28B

YoY Change+37.6%—

5-Year CAGR+22.8%FY2020 → FY2018

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2007

▸ FMP /income-statement · Annual · CELG-RI net income history · CELG-RI profit margin

Annual net income data

CELG-RI · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2018$4.05B▲ +37.6%26.5%$15.28B

FY2017$2.94B▲ +47.1%22.6%$13.00B

FY2016$2.00B▲ +24.8%17.8%$11.23B

FY2015$1.60B▼ 19.9%17.3%$9.26B

FY2014$2.00B▲ +37.9%26.1%$7.67B

Net income vs peers (Healthcare)

CELG-RI vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Bristol-Myers Squibb Company CeYOU

CELG-RI

$4.05B+37.6%26.5%

15%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Bristol-Myers Squibb Company Ce (CELG-RI) reported net income of $4.05B for FY2018 (fiscal year ending 2018-12-31), up 37.6% year-over-year. The net profit margin was 26.5% — meaning the company kept $0.26 of every dollar of revenue as profit.

Based on available data, Bristol-Myers Squibb Company Ce has been profitable since at least 2007. Net income reached a peak of $4.05B in FY2018. Data available for 12 fiscal years.

Bristol-Myers Squibb Company Ce's net profit margin was 26.5% for FY2018, based on the latest annual results.

Investors sometimes search for "Bristol-Myers Squibb Company Ce net worth" — the company's market capitalization is a separate figure from CELG-RI net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

CELG-RI net income · 5 questions

Bristol-Myers Squibb Company Ce is profitable. The company reported net income of $4.05B for FY2018, a net profit margin of 26.5%. Net income was up 37.6% year-over-year. Based on available data, Bristol-Myers Squibb Company Ce has been profitable since at least 2007.

is CELG-RI profitabledoes CELG-RI make a profitCELG-RI profitabilityCELG-RI profitable company

▸ Source: FMP /income-statement · GAAP · Bristol-Myers Squibb Company Ce · Bristol-Myers Squibb Company Ce SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026